Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIAbetes-PREvention Trial in coronary artery disease patients with pre-diabetes
NL-OMON38088Suspended
- Sponsor
- Isala
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of metformin in prediabetes and coronary arteriosclerosis (3 arms), sponsored by Isala. Primary endpoint: HbA1c reduction at one year. Started Mar 2012; status: suspended.
02
Drugs
metformin
03
Conditions
prediabetescoronary arteriosclerosis
Beyond the preview
Go deeper on NL-OMON38088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38088.